ENTITY
BB Biotech AG

BB Biotech AG (BION SW)

9
Analysis
Health CareSwitzerland
BB Biotech AG is a closed-ended investment trust. It invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.
more
Refresh
bullishBB Biotech AG
25 Oct 2023 19:10Issuer-paid

BB Biotech - A cutting-edge sector and a high dividend

BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. BION is the largest biotech investor among its...

Share
bullishBB Biotech AG
03 Mar 2023 20:05Issuer-paid

BB Biotech - Picking growth at good value

According to BB Biotech’s (BION’s) investment team, the biotech industry remains in a very good position. Following a sell-off in the last two...

Share
bullishBB Biotech AG
13 Sep 2022 22:56Issuer-paid

BB Biotech - Great valuation potential

According to BB Biotech’s (BION) investment team, the biotech industry has never looked in such a good position. Following a sell-off in the last...

Share
bullishBB Biotech AG
15 Dec 2020 20:08Issuer-paid

Video: BB Biotech - fund manager interview

Daniel Koller, lead fund manager of Switzerland-based BB Biotech, reflects on an extraordinary year for the world at large and the healthcare...

Share
bullishBB Biotech AG
16 Apr 2020 19:02Issuer-paid

BB Biotech - RNA focus provides a possible COVID-19 solution

BB Biotech (BION) recently updated the market on its views on the COVID-19 pandemic and how they are reflected in its portfolio (see video link...

Share
x